ORIC Pharmaceuticals, Inc. · LS:A2P208

ORIC Pharmaceuticals, Inc. financial statements

ORIC Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue00000000
Cost of revenue1.22M1.11M1.03M966.0K897.0K970.0K1.00M900.0K900.0K
Gross profit-1.22M-1.11M-1.03M-966.0K-897.0K-970.0K-1.00M-900.0K-900.0K
Research and development109.8M114.1M85.2M61.7M56.9M35.9M22.8M19.0M19.1M
Selling, general and administrative33.2M28.8M25.6M25.1M22.0M13.4M5.72M3.35M3.42M
Operating income-143.0M-142.9M-110.8M-91.8M-78.9M-74.2M-28.6M-22.4M-22.5M
Depreciation and amortization1.22M1.11M1.03M966.0K897.0K970.0K1.03M903.0K900.0K
EBITDA-141.8M-141.8M-109.7M-90.8M-78.0M-73.2M-27.5M-21.5M-21.6M
Interest expense2.65M141.0K306.0K1.69M1.01M0
Income before tax-129.5M-127.8M-100.7M-89.1M-78.7M-73.7M-26.9M-21.4M-22.0M
Income tax00000000
Net income-129.5M-127.8M-100.7M-89.1M-78.7M-73.7M-26.9M-21.4M-22.0M
Earnings per share, basic-1.47-1.83-1.96-2.25-2.07-3.36-14.15-12.32-15.62
Earnings per share, diluted-1.47-1.83-1.96-2.25-2.07-3.36-14.15-12.32

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents45.7M59.4M23.4M66.8M226.0M78.4M89.2M42.6M25.8M
Short-term investments235.8M196.6M184.8M139.4M11.0M215.2M
Current assets288.5M262.3M212.6M210.5M240.5M296.7M90.0M43.7M26.6M
Property, plant and equipment2.42M2.92M2.86M3.25M2.41M1.98M2.24M2.51M2.90M
Total assets408.9M274.1M252.0M247.2M298.6M299.0M94.1M46.7M30.0M
Accounts payable3.82M1.55M944.0K1.32M1.89M757.0K152.0K446.0K940.0K
Current liabilities20.4M24.8M20.5M15.4M15.2M9.00M5.35M2.60M2.61M
Total debt3.33M3.18M10.2M12.1M10.5M
Total liabilities24.5M31.0M27.9M24.8M25.7M9.22M6.12M111.2M4.30M
Shareholders' equity384.4M243.1M224.1M222.4M273.0M289.8M-90.1M-64.4M25.7M
Shares outstanding98.5M71.0M54.9M45.1M39.4M36.7M1.98M39.4M1.41M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-111.0M-112.7M-85.7M-75.1M-59.5M-45.3M-23.5M-20.7M-20.8M
Capital spending-712.0K-1.19M-849.0K-2.08M-939.0K-667.0K-768.0K-525.0K-486.0K
Free cash flow-111.7M-113.8M-86.5M-77.2M-60.5M-45.9M-24.3M-21.2M-21.3M
Cash from investing-148.0M22.1M-43.4M-109.2M158.4M-216.0M-768.0K-508.0K-292.0K
Cash from financing245.3M126.5M85.7M25.2M49.1M250.5M70.8M38.0M260.0K
Share buybacks545.0K51.0M271.8M70.9M38.0M
Change in cash-13.7M36.0M-43.4M-159.2M148.0M-10.7M46.5M16.8M-20.9M